Joe Bress

Managing Director, U.S. Buyout, Healthcare Group, Carlyle

Joe Bress is a Managing Director on the U.S. Buyout team at Carlyle, focusing on investments in the healthcare sector. He is based in New York. Since joining Carlyle in 2007, Joe has been involved in investing and managing over $5 billion of equity investments into healthcare companies globally. Joe has actively been involved with investments in Curia Global, CorroHealth, Included Health, Millicent Pharma, Orsini Specialty Pharmacy, PPD, Rede D’Or São Luiz, Saama, TriNetX, WellDyneRx, and X-Chem. He is also involved in Carlyle’s broader life sciences efforts, including the recent acquisition of Abingworth. Prior to Carlyle, Joe worked in the Mergers & Acquisitions group at UBS. Joe serves as a director on the boards of Curia Global, CorroHealth, Millicent Pharma, Orsini Specialty Pharmacy, Saama, TriNetX, and WellDyneRx. Joe received his M.B.A. from Stanford University and an A.B. from Harvard University, where he graduated magna cum laude.